A major mechanism of neurotransmitter inactivation at catecholaminergic synapses is reuptake ofreleased transmitter at high-affinity uptake sites on presynaptic terminals. We have analyzed the anatomical distribution of siteselective ligand binding for dopamine uptake sites in the striatum of rat, cat, and monkey. We report here that desipramine-sensitive [31H]mazindol binding sites have highly heterogeneous distributions in the dorsal and the ventral striatum.
In the caudate nucleus of cat and monkey, [3Hlmazindol binding observes striosomal ordering, being reduced in striosomes and heightened in the extrastriosomal matrix. Some local heterogeneity appears in the ventral caudoputamen of the rat.
Different subdivisions of the nucleus accumbens also have different binding levels. These rmfdings suggest that some functional effects of psychoactive drugs, such as cocaine, that bind to the dopamine-uptake complex could be related to the distribution of these specific uptake sites. The rindings also raise the possibility that these distributions could result in selective neuronal vulnerability to neurotoxins, such as 1-methyl4-phenylpyridine (MPP+), that depend on the dopamine-uptake complex for entry into neurons.
A number of powerful psychoactive drugs, including cocaine and amphetamine, bind to sites on the presynaptic uptake complex that constitutes a major means for neurotransmitter inactivation at catecholaminergic synapses (1) (2) (3) . Catecholamine-uptake sites are also potential conduits for the entry of neurotoxins and neurotoxin precursors into catecholaminergic synapses. This route is ofspecial interest in relation to the drug-induced parkinsonian syndrome elicited by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) (4) (5) (6) . The toxic oxidative metabolite of MPTP, 1-methyl-4-phenylpyridine (MPP+) , is thought to enter catecholaminecontaining neurons by means of the uptake transport mechanism (7, 8) . Blockade of dopaminergic and noradrenergic uptake sites with specific blockers prevents the toxic effects of MPTP administration on dopaminergic and noradrenergic neurons (9) (10) (11) (12) . The precise distribution of high-affinity uptake sites within the catecholaminergic systems of the brain is thus important not only in relation to the normal physiology of these pathways but also in relation to the selective effects of drugs and environmental toxins on catecholaminergic function.
In the experiments reported here we used in vitro ligandbinding autoradiography with the radiolabeled catecholamine uptake blocker [3H]mazindol in the presence of desipramine (13, 14) to study the detailed distribution of high-affinity dopamine uptake sites in the striatum. The results suggest that in cat and monkey there are notable differences in the amounts of [3H]mazindol binding in the two main tissue compartments of the dorsal striatum, the striosomes and the extrastriosomal matrix (15); and they suggest that different subdivisions of the ventral striatum in rat, cat, and monkey are also characterized by different levels of binding. These differential anatomical distributions may help to account for some of the functional and toxicological selectivities of drugs acting on the mesostriatal system.
MATERIALS AND METHODS
Brains were removed from one cat, two rats, (one SpragueDawley; one Wistar), one squirrel monkey, and one cynomolgus monkey after induction of terminal anaesthesia with sodium pentobarbital (Nembutal). Blocks containing the striatum were frozen in pulverized dry ice and were cut transversely at 20 gm on a cryostat immediately or after brief storage at -70'C. Sections cut at -12'C and thaw-mounted onto "subbed" slides were dried at 40C in a dessicator under vacuum, stored at -20'C for at least 2 weeks, and then incubated according to the protocols of O'Dell and Marshall (14) and Javitch et al. (13) . For autoradiographic studies, sections were preincubated in 50 mM Tris-HCl (pH 7.9) containing 120 mM NaCI and 5 mM KCI at 40C (5 min), then incubated in 50 mM Tris HCl (pH 7.9) containing 300 mM NaCl, 5 
DISCUSSION
These observations have implications of at least two types. First, the findings indicate that pharmacologic treatments affecting the dopamine uptake mechanism may have differential effects on the striosome and matrix subdivisions of the dorsal striatum and on distinct subdivisions of the ventral striatum. Second, the findings suggest that entry of potential toxins into dopamine-containing fibers in the striatum could be different for these striatal compartments.
For the dorsal striatum the differences in [PH]mazindol binding were clearest in the caudate nucleus and, among species, were sharpest in the cat and only occasionally detectable, and then only ventrally, in the rat's caudoputamen. The lower numbers of uptake sites available for the binding of [3H]mazindol in striosomes suggest that there either are fewer dopamine-containing terminals in this striatal compartment or are fewer sites per terminal in striosomes than in the extrastriosomal matrix, or, conceivably, that the sites in the two striatal compartments have different molecular conformations although both bind [3H]mazindol. There is no direct evidence yet to settle this issue. Both striosomes and matrix are richly innervated by fibers from the midbrain, but different cell groups within the nigral complex innervate the two striatal compartments to different extents (18) (19) (20) . Striosomes have lower tyrosine hydroxylase-like immunoreactivity than the extrastriosomal matrix (21, 22 Numbers in parenthesis refer to n. *Significantly different from binding in matrix at P < 0.0001. (25)] but also by presynaptic markers. Interestingly, all of these markers display greater compartmental selectivity in the caudate nucleus than in the putamen and are not as clearly compartmental in distribution in the rat (if they are at all) as they are in carnivores and primates. Amphetamine treatment in the rat has, however, been found to induce patchy anatomical distributions of transmitter-related compounds, including (presynaptic) tyrosine hydroxylase-immunoreactive patches (26) and (postsynaptic) dynorphin immunoreactive patches (27) .
D2-selective ligand binding [heightened in the matrix
If synpatic release of dopamine is mainly from the newly synthesized pool of transmitter (28) , the difference in number of uptake sites shown here for striosomes and matrix (about 50% maximum detected difference) might not be reflected functionally in these normally slow-firing neurons. Clearly, however, with intense firing and transmitter release or under the influence of drugs inducing massive transmitter release, differences in the capacity for transmitter clearance by reuptake could be functionally significant. Uptake-site blockade by agents such as cocaine could also have markedly different effects on striosomes and matrix. Interpretation of such differences is now constrained by lack of information about the distribution of uptake sites on single terminals in striosomes and matrix; but given that the [3H]mazindol binding site has been directly related to the [3H]cocaine binding site on the dopamine uptake-site complex (2), the present results suggest that striosome-matrix differences in uptake-site distribution should be taken into account in addition to compartmental differences in D1/D2-binding-site ratios in analyzing drug effects on the nigrostriatal system.
There are considerable dose-response differences in the behavioral effects of drugs affecting catecholamine uptake sites, and some of these relate to the different expression of behaviors thought to be mediated preferentially by sensorymotor and limbicohypothalamic mechanisms (2, 29, 30) . The contrasting pre-and postsynaptic character of the dopamine innervations of striosomes and matrix could be essential to an understanding of these drug effects, for striosomes are preferentially related to a subset of limbic pathways and project to the substantia nigra, whereas the extrastriosomal matrix is linked to sensorimotor regions and other limbic pathways and projects preferentially into pallidothalamic and nigrotectal pathways (for review, see ref. 31) .
For the dopamine-containing mesolimbic system, there also were striking regional inhomogeneities in uptake-site distribution, and these regional differences were at least as marked as those for striosomes and matrix in the dorsal striatum. Marshall (32) (34) and Turner et al. (35) in dogs acutely exposed to MPITP. At 8-14 days after MPTP injection, these authors found intense degeneration of fibers in the extrastriosomal matrix with relative sparing of fibers in the striosomes. They also describe the striosomal pattern as being clearest in the caudate nucleus at rostral and midanterior levels and illustrate fiber degeneration in the nucleus accumbens mainly in the lateral rather than the medial part of the nucleus.
Given the findings presented here, serious consideration should be given to the possibility that such differential patterns of MPTP-induced fiber degeneration might reflect local inhomogeneities in uptake-site distribution within the striatum, just as, in general, the greater vulnerability of more dorsal than more ventral striatal regions might be related to gradients of uptake-site distribution (27) . The possibility that local variations in uptake-site distribution within the striatum constrain the level of degeneration induced by acute exposure to MPTP is in accord with the finding that intrastriatal administration of MPTP can induce degenerative changes in neurons in the midbrain (36, 37) . Such differential vulnerability of fiber terminals could account for patterns of partial sparing of midbrain neurons seen with dose schedules producing submaximal damage to the system (38, 39) . To the extent that the MPTP model relates to other forms of parkinsonism, the compartmental distributions of uptake sites described here could be important in constraining patterns of mesencephalic neuronal loss in these disorders as well (40) .
